Deutsche Bank Believes Siemens Healthineers AG (SEMHF) Still Has Room to Grow

In a report released today, Falko Friedrichs from Deutsche Bank upgraded Siemens Healthineers AG (SEMHF) to Buy, with a price target of EUR56.00. The company’s shares closed last Monday at $58.20, close to its 52-week high of $60.50.

According to, Friedrichs is ranked #1890 out of 7491 analysts.

Siemens Healthineers AG has an analyst consensus of Moderate Buy, with a price target consensus of $62.58, which is a 7.5% upside from current levels. In a report issued on April 19, Kepler Capital also upgraded the stock to Buy with a EUR52.00 price target.

See today’s analyst top recommended stocks >>

Based on Siemens Healthineers AG’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.87 billion and net profit of $432 million. In comparison, last year the company earned revenue of $3.59 billion and had a net profit of $301 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts